BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AngioChem 

201 President-Kennedy Avenue
Suite PK-R210
Montreal  Quebec  H2X 3Y7  Canada
Phone: 514-788-7800 Fax: 514-788-7801


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
AngioChem Presents Positive Data On ANG1005 In Brain Mets, Launches Phase 2, Gets Orphan Drug/Fast Track 5/30/2014 10:09:58 AM
AngioChem's ANG1005 Received Fast Track And Orphan Drug Designation From FDA For The Treatment Of Glioblastoma Multiforme 5/30/2014 6:38:21 AM
AngioChem To Present Clinical Data At The American Society of Clinical Oncology 2014 Annual Meeting 5/15/2014 9:53:48 AM
Preclinical Data On AngioChem Pain Program Published In Journal Of Clinical Investigation 2/18/2014 9:58:18 AM
AngioChem Demonstrates Peptide Antibody Conjugate That Successfully Crosses The Blood Brain Barrier And Increases Survival In HER-2 Positive Brain Tumors 12/16/2013 9:39:04 AM
AngioChem To Present Data On Its Lead Oncology Compounds At The 2013 San Antonio Breast Cancer Symposium 12/5/2013 7:37:37 AM
AngioChem’s ANG1005 For Primary Brain Cancer And Brain Metastasis Selected As A Top 10 Project To Watch 11/12/2013 9:17:32 AM
Phase 2 Clinical Data for AngioChem's Lead Drug Candidate, ANG1005, in Breast Cancer Patients With Brain Metastases Revealed 10/21/2013 12:24:01 PM
AngioChem to Present at the American Society of Human Genetics 2013 Annual Meeting 10/17/2013 6:48:35 AM
AngioChem to Present at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 10/8/2013 7:44:38 AM
12345